Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
about
Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signalingAngiomotin is a novel Hippo pathway component that inhibits YAP oncoproteinMEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancermicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinomaThe hippo signaling pathway in development and cancerEmerging role of Hippo pathway in gastric and other gastrointestinal cancersThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentTargeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyEmerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancerHippo/YAP pathway for targeted therapyThe Hippo-YAP pathway in organ size control and tumorigenesis: an updated versionDickkopfs and Wnt/β-catenin signalling in liver cancerThe role of YAP transcription coactivator in regulating stem cell self-renewal and differentiationHippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liverGene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinomaValidation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motifThe role of the Hippo pathway in human disease and tumorigenesisCytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP.The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesisExpression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinomaFbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cellsExpression of hippo pathway in colorectal cancer.Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancerThe Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.Cancer gene discovery in hepatocellular carcinomaPP1A-mediated dephosphorylation positively regulates YAP2 activityYes-associated protein expression in head and neck squamous cell carcinoma nodal metastasisMiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.Control of tissue growth and cell transformation by the Salvador/Warts/Hippo pathway.Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomyHippo pathway effector Yap is an ovarian cancer oncogene.YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.Sub-cellular localisation studies may spuriously detect the Yes-associated protein, YAP, in nucleoli leading to potentially invalid conclusions of its function.Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth.
P2860
Q24294906-17823548-B267-4DE0-9004-D7F8E7984AC8Q24323326-44BB8ED2-3A02-46DA-AC63-79F36CB4217BQ24339513-0904F456-7600-447C-9EBE-11166187939BQ24595141-F579984B-2850-4F5B-98B6-39F99C00B58FQ24603986-4A77816E-C063-4238-A1B9-ABC31291192FQ26774473-3954B7B5-0EA7-4AFC-BE7C-BACE9FA63715Q27025661-4CF71914-A92F-4F93-8C37-53DD721C0C13Q28078129-96199E67-ADC9-47C3-8DD0-F675CF4E59CCQ28086905-95AFFE74-534E-4BCF-B829-73AF64D6C66FQ28088294-D04D7C4D-786E-4CEA-8F62-91EECB150858Q28281214-B126105B-0DA4-4D64-916C-CA2492FE6EC6Q28391394-D600C870-3F4B-473A-B10E-E10576FC3A3FQ28507317-8A558FB6-4085-45E7-B411-FE3C6BF1E93DQ28587974-C879C430-6703-43D6-873A-68E3DEBEB1FAQ28740309-3026B391-BAFB-4DAA-A4DA-DE1146E95A9AQ28828305-E9CFAE0B-C990-4A24-A959-01D0AD5F8E82Q30433413-34C12558-F090-4325-BF90-891739EF0343Q30854449-DA5BEF71-4E9D-476C-9D86-96CC3B145590Q33654365-3AC3F697-E3E3-436B-8C77-018C9F4CEBF5Q33672296-F68301A1-5290-4554-A4F2-16137B5CA50DQ33673983-FC9F1B82-244F-47F8-A699-B70F245CFE31Q33709820-3E0CB56E-7044-468C-80CA-3906DA451ADEQ33796051-12CCDFF8-97D8-447B-A888-F7871780580CQ33817465-AFAF394A-56AB-48CA-97A6-0FE052A4FACFQ33929406-60DB6AE7-D490-4960-AC93-E70C168BFDE4Q34002120-640D688B-6832-41C4-AF25-49E0C760C987Q34016621-86709CD3-AEE8-4391-8414-6F9641AEDDBAQ34077954-6D8F8E32-0D84-41FC-AAFB-0478F9F664A1Q34138366-C45AE7C7-6FB8-4DA1-AC45-6137C2D7C8BDQ34168500-25A72030-9F1C-44D4-9CE6-111885BF8904Q34253205-2D56050B-5601-4D4C-BF33-D90E422F2A7CQ34267908-6316930A-8116-4D66-BB25-933926632D10Q34463878-954FC9BE-E59A-4CC3-A77D-6D2E34BD68BDQ34759794-D7FF09C8-6870-459C-A72C-598EEBA490BDQ34770004-B3BFB3EE-8D1E-4872-996D-AFBEDF3107C5Q34775779-B259E5C0-8543-48E5-9196-B11361790683Q34840601-3D1D1B6F-D877-44F2-8DB4-F9E587DB204CQ35005633-91DD553E-26DF-4E50-A88E-A20BE457FE2EQ35058951-1BFCB99F-7807-47D6-872E-9A7F304223E2Q35089015-24C6EA88-FF79-43C8-A023-29E2730F899E
P2860
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
@ast
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
@en
type
label
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
@ast
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
@en
prefLabel
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
@ast
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
@en
P2093
Irene O L Ng
John M Luk
Lars Zender
Michelle Z Xu
Nikki P Y Lee
Ronnie T P Poon
Scott W Lowe
Tzy-Jyun Yao
Yuk-Tat Chan
P2860
P304
P356
10.1002/CNCR.24495
P407
P50
P577
2009-10-01T00:00:00Z